News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novel Kinase Inhibitor Promising in NSCLC, Umea University Study


10/28/2010 6:34:53 AM

MedPageToday -- Non-small cell lung cancers and other tumors with a mutation in anaplastic lymphoma kinase (ALK) respond dramatically to a novel agent that "switches off" the faulty gene, according to early trial results.

Read at MedPageToday


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES